Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.82 |
| ▸ | NPC1 | O15118 | 3/20 | 0.82 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.73 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA6 | P23280 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL312910 | 0.91 | TDP1 (0.81) | RAB9ANPC1TDP1KMT2ASLC6A2 | |
| SCHEMBL24515889 | 0.89 | RAB9A (0.67) | RAB9ANPC1TDP1KMT2ASLC6A2 | |
| SCHEMBL181934 | 0.86 | TDP1 (0.73) | RAB9ANPC1TDP1KMT2ASLC6A2 | |
| SCHEMBL9696689 | 0.86 | TDP1 (0.72) | RAB9ANPC1TDP1KMT2ASLC6A2 | |
| SCHEMBL9166162 | 0.86 | TDP1 (0.72) | RAB9ANPC1TDP1KMT2ASLC6A2 | |
| SCHEMBL10980613 | 0.85 | ESR1 (0.69) | RAB9ANPC1TDP1KMT2ASLC6A2 | |
| Benzyl Benzoate SCHEMBL3038 | 0.85 | KMT2A (1.00) | RAB9ANPC1TDP1KMT2ASLC6A2 | |
| Benzyl Benzoate SCHEMBL901058 | 0.85 | KMT2A (1.00) | RAB9ANPC1TDP1KMT2ASLC6A2 | |
| Benzyl Benzoate SCHEMBL8010992 | 0.85 | KMT2A (1.00) | RAB9ANPC1TDP1KMT2ASLC6A2 | |
| SCHEMBL318600 | 0.85 | TDP1 (0.71) | RAB9ANPC1TDP1KMT2ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114989501-A | Non-toxic environment-friendly foamed natural rubber and preparation method thereof | 唐雪金 | 2022-09-02 | — | — | CN | claimed |
| CN-108635361-B | A flos Viburni Sargentii extract with antiinflammatory activity, and its active ingredient and separation method | 扬州大学 | 2020-02-07 | — | — | CN | claimed |
| JP-5078610-A | — | — | None | — | — | JP | disclosed |
| JP-59042998-A | — | — | None | — | — | JP | disclosed |
| CN-117794526-A | Compositions and methods for antioxidants and anti-inflammatory therapeutics | 阿万蒂生物科学股份有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-108472381-B | Compounds and therapeutic uses thereof | 森陶里治疗有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-114989501-A | Non-toxic environment-friendly foamed natural rubber and preparation method thereof | 唐雪金 | 2022-09-02 | — | — | CN | disclosed |
| CN-109456324-B | Isoindoline or isoquinoline compounds, process for their preparation and pharmaceutical compositions containing them | 法国施维雅药厂 | 2022-04-22 | — | — | CN | disclosed |
| US-20210369850-A1 | COMPOUNDS AND THERAPEUTIC USES THEREOF | Centauri Therapeutics Limited (GB/GB) (GB) | 2021-12-02 | — | — | US | disclosed |
| US-11028070-B2 | Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2021-06-08 | — | — | US | disclosed |
| US-10953100-B2 | Compounds and therapeutic uses thereof | CENTUARI THERAPEUTICS LIMITED (GB/GB) (GB) | 2021-03-23 | — | — | US | disclosed |
| EP-0749316-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1996-12-27 | — | — | EP | disclosed |
| WO-1995023608-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1995-09-08 | — | — | WO | disclosed |
| JP-H0578610-A | INK COMPOSITION FOR INK JET RECORDING | RICOH CO LTD | 1993-03-30 | — | — | JP | disclosed |
| EP-0249885-B1 | HEAT-SENSITIVE RECORDING MATERIAL | KANZAKI PAPER MANUFACTURING COMPANY LIMITED (JP) | 1992-01-02 | — | — | EP | disclosed |
| US-4794101-A | MIXTURE OF PHTHALIDE DYE, FLUORAN COMPOUND AND POLYVALENT METAL SALT OF AN AROMATIC CARBOXYLIC ACID | KANZAKI PAPER MANUFACTURING CO., LTD. (JP) | 1988-12-27 | — | — | US | disclosed |
| EP-0249885-A2 | Heat-sensitive recording material | KANZAKI PAPER MANUFACTURING COMPANY LIMITED (JP) | 1987-12-23 | — | — | EP | disclosed |
| JP-S5942998-A | HEAT SENSITIVE RECORDING MATERIAL | RICOH CO LTD | 1984-03-09 | — | — | JP | disclosed |
| US-4348410-A | Cyclohexane carboxylic acid derivatives | NIPPON CHEMIPHAR CO., LTD. (JP) | 1982-09-07 | — | — | US | disclosed |
| US-4145342-A | NITRO-DIPHENYLAMINO-AZO-PHENYL DYESTUFFS CONTAINING A POLYALKYENEOXY GROUP | BAYER AKTIENGESELLSCHAFT (DE) | 1979-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210369850-A1 | COMPOUNDS AND THERAPEUTIC USES THEREOF | CD47, MYD88, NFATC1 | RAB9A 1262/4885NPC1 583/4885TDP1 2823/4885 |
| US-10953100-B2 | Compounds and therapeutic uses thereof | CD47, MYD88, NFATC1 | RAB9A 1262/4885NPC1 583/4885TDP1 2823/4885 |
| US-11028070-B2 | Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them | BAX, RECQL, CASP7 | RAB9A 139/4885NPC1 1358/4885TDP1 1009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.